Syneos Health Appoints Costa Panagos as Chief Executive Officer
09 oct. 2024 09h00 HE
|
Syneos Health, Inc.
Colin Shannon Appointed Executive Chairman Seasoned Executive Further Strengthens Company’s Leadership Team MORRISVILLE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully...
Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients
23 mai 2024 10h53 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 23, 2024 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named six distinguished colleagues...
Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
26 juin 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
25 mai 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha...
Syneos Health Leaders Recognized by HBA
17 mai 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP...
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
16 mai 2023 08h05 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
13 avr. 2023 16h31 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...
Syneos Health Wins 2023 ViE Award
05 avr. 2023 07h30 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded...
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
16 févr. 2023 06h03 HE
|
Syneos Health, Inc.
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 16h31 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...